Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening

Bioorganic & Medicinal Chemistry Letters
2013.0

Abstract

Through structure-based virtual screening, some dozen of benzene sulfonamides with novel scaffolds are identified as potent inhibitors against carbonic anhydrase (CA) IX with IC50 values ranging from 2.86 to 588.34 nM. Among them, compounds 1 and 9 show high selectivity against tumor-target CA IX over CA II (the selectivity ratios are 21.3 and 136.6, respectively). The possible binding poses of hit compounds are also explored and the selectivity is elucidated by molecular docking simulations. The hit compounds discovered in this work would provide novel scaffolds for further hit-to-lead optimization.

Knowledge Graph

Similar Paper

Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening
Bioorganic & Medicinal Chemistry Letters 2013.0
Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship
European Journal of Medicinal Chemistry 2013.0
Novel benzoyl thioureido benzene sulfonamides as highly potent and selective inhibitors of carbonic anhydrase IX: optimization and bioactive studies
MedChemComm 2018.0
Discovery and Characterization of Novel Selective Inhibitors of Carbonic Anhydrase IX
Journal of Medicinal Chemistry 2014.0
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors
Journal of Medicinal Chemistry 2018.0
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors
ACS Medicinal Chemistry Letters 2023.0
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases
ACS Medicinal Chemistry Letters 2017.0
Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors
Bioorganic & Medicinal Chemistry 2009.0
Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII
Bioorganic & Medicinal Chemistry 2016.0
Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII
European Journal of Medicinal Chemistry 2015.0